Feb 5 (Reuters) - Medical device maker Boston Scientific ( BSX )

forecast annual profit above Wall Street estimates on

Wednesday, banking on steady demand for its heart devices.

Manufacturers of medical devices have been benefiting from

the elevated demand for elective surgical procedures in the

United States, especially among older adults.

Boston Scientific ( BSX ), which generates most of its revenue from

sales of heart devices such as pacemakers and stents, also

produces equipment for diagnosing and treating a range of

gastrointestinal and pulmonary conditions.

The company expects its 2025 adjusted earnings to be in the

range of $2.80 to $2.87 per share, above analysts' average

expectation of $2.81 at the midpoint, according to data compiled

by LSEG.

Boston Scientific ( BSX ) projected full-year revenue growth between

12.5% and 14.5%, compared with the prior year.

The company's key growth drivers include its stroke

prevention device, Watchman, and Farapulse, which uses short

high-voltage pulses to treat certain abnormal heart rhythm

conditions.

The initial 2025 guide is "strong out of the gates and we

see room for the company to beat and raise through the year with

PFA (Farapulse) as a key driver," RBC Capital analyst Shagun

Singh said.

The results and the forecast "continue to point to a

positive read-through to the rest of the sector," Singh added.

Boston Scientific's ( BSX ) revenue increased 22.4% to $4.56 billion

for the fourth quarter, surpassing expectations of $4.43

billion.

Sales at the company's cardiovascular unit rose nearly 29%

to $2.94 billion in the three months ended Dec. 31, beating

estimates of $2.83 billion.

The company's endoscopy unit, which includes devices used in

surgical procedures that aid in weight loss, reported a 7% rise

in its quarterly revenue of $690 million. Analysts were

expecting the unit to report sales of $695.9 million.

Boston Scientific ( BSX ) earned 70 cents per share on an adjusted

basis in the fourth quarter, topping estimates of 66 cents.